BullFrog AI – Gleaning Actionable Insights from High Dimensional Data
Vin Singh, Founder and CEO of BullFrog AI, a precision medicine company, discusses their bfLEAP Platform and how leveraging the power of AI and machine learning can quickly digest and analyze large sets of data and reveal insights about treatment response against patient populations which will improve selection for clinical trials and boost success rates.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Therapy. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Therapy and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Therapy?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Vin Singh, Founder and CEO of BullFrog AI, a precision medicine company, discusses their bfLEAP Platform and how leveraging the power of AI and machine learning can quickly dige…
- Key Point: Vin Singh, Founder and CEO BullFrog AI Founder & former CEO, Next Healthcare Inc.
- Key Point: – Nasdaq (MXCT) – $1.5B market cap Global Director, Cell Therapy – ThermoFisher Scientific B.S.
- Key Point: Electrical Engineering, Rutgers University M.S.
- Key Point: Biomedical Engineering, Rensselaer Polytechnic Institute MBA, The Johns Hopkins University
Vin Singh, Founder and CEO BullFrog AI
Founder & former CEO, Next Healthcare Inc.
Co-founder, MaxCyte Inc. – Nasdaq (MXCT) – $1.5B market cap
Global Director, Cell Therapy – ThermoFisher Scientific
B.S. Electrical Engineering, Rutgers University
M.S. Biomedical Engineering, Rensselaer Polytechnic Institute
MBA, The Johns Hopkins University
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



